Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

Medicine & Life Sciences

• tisagenlecleucel 100%
• Lymphoma, Large B-Cell, Diffuse 60%
• Cytokine Release Syndrome 24%
• Chimeric Antigen Receptors 20%
• Cell- and Tissue-Based Therapy 14%
• Disease Progression 12%
• Anniversaries and Special Events 9%
• Febrile Neutropenia 9%
• T-Lymphocytes 9%
• Brain Edema 8%
• Hematopoietic Stem Cell Transplantation 8%
• Advisory Committees 8%
• Stem Cell Transplantation 7%
• B-Cell Lymphoma 7%
• Nervous System 6%
• B-Lymphocytes 5%
• Confidence Intervals 4%
• Recurrence 4%
• Survival 4%
• Infections 3%
• Proteins 2%
• Neoplasms 2%
• Therapeutics 1%